Arcturus Therapeutics develops mRNA medicines for rare diseases and a COVID-19 vaccine, KOSTAIVE, with partner CSL Seqirus. It last closed at $7.45 on Nov 20, down 1.97% on the day. The next earnings report for ARCT is expected around Tue, Mar 2, 2027, after the close. For the quarter ended Sep 2026, ARCT reported EPS of -$0.26 on revenue of $18.3M, with revenue up 6.7% from a year ago. Over its last 8 reports the stock moved an average of 10.4% the session after earnings.
AI Auto Pilots
Is ARCT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ARCT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ARCTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ARCT · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 28% below its 20 day and 57% below its 50 day average. It is 22% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot S1 at $7.26, and the nearest resistance the Pivot at $7.50.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 13.2%/day
Key levels
$17.9652 week high+141.1%
$11.7250 day average+57.3%
$10.56100 day average+41.7%
$9.5220 day average+27.8%
$9.12200 day average+22.4%
$7.87Swing high (Jun 22)+5.6%
$7.68Pivot R1+3.1%
$7.50Pivot+0.7%
$7.45Last close
$7.26Pivot S1−2.6%
$6.71Swing low (Jun 11)−9.9%
$5.5052 week low−26.2%
Indicators
RSI (14)
33.07
Weak, oversold below 30
Neutral
MACD
-1.08
Below its signal line
Bearish
Stochastic
4.8
Near the bottom of its range
Oversold
ADX (14)
19.7
No clear trend
Williams %R
-96.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-136.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−28.0%
Change over 10 sessions
Bearish
ATR (14)
$0.98
Typical daily range, 13.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 30.8%/day
Key levels
$17.9652 week high+141.1%
$11.7250 day average+57.3%
$10.56100 day average+41.7%
$9.5220 day average+27.8%
$9.12200 day average+22.4%
$7.87Swing high (Jun 22)+5.6%
$7.68Pivot R1+3.1%
$7.50Pivot+0.7%
$7.45Last close
$7.26Pivot S1−2.6%
$6.71Swing low (Jun 11)−9.9%
$5.5052 week low−26.2%
Indicators
RSI (14)
41.11
Middle of its range
Neutral
MACD
0.17
Below its signal line
Bearish
Stochastic
17.5
Near the bottom of its range
Oversold
ADX (14)
25.1
Trending up
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-57.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−49.4%
Change over 10 sessions
Bearish
ATR (14)
$2.30
Typical daily range, 30.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ARCT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ARCT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ARCT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ARCTHow many large options trades hit ARCT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ARCT in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ARCT is in one of them and how their past ARCT trades turned out.
Arcturus Therapeutics is a messenger RNA medicines company based in San Diego, California. It develops treatments for rare genetic diseases, including candidates for ornithine transcarbamylase deficiency and cystic fibrosis. The company also develops vaccines, and its KOSTAIVE COVID-19 vaccine is partnered with CSL Seqirus and sold in Japan through Meiji Seika Pharma. Its proprietary LUNAR delivery system and STARR platform are used to build these medicines and vaccines.